NEW YORK – The Parkinson's Foundation has launched a nationwide genetics project that will analyze potential biomarkers for Parkinson's disease (PD) to improve clinical care and offer new treatment options for patients. Called PD GENEration: Mapping the Future of Parkinson's Disease, the initiative will include sequencing efforts from Fulgent Genetics and database management support from several academic institutions.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.